| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Kingchem (Liaoning) Life Science Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥29.48 |
| 52 Week High | CN¥73.04 |
| 52 Week Low | CN¥24.36 |
| Beta | 0 |
| 11 Month Change | 15.29% |
| 3 Month Change | -18.97% |
| 1 Year Change | -52.54% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -43.09% |
Recent News & Updates
Shareholder Returns
| 301509 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 19.9% | 6.5% | 9.6% |
| 1Y | -52.5% | -14.9% | -12.3% |
Return vs Industry: 301509 underperformed the CN Pharmaceuticals industry which returned -14.9% over the past year.
Return vs Market: 301509 underperformed the CN Market which returned -12.3% over the past year.
Price Volatility
| 301509 volatility | |
|---|---|
| 301509 Average Weekly Movement | 6.7% |
| Pharmaceuticals Industry Average Movement | 5.1% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in CN Market | 8.4% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 301509's share price has been volatile over the past 3 months.
Volatility Over Time: 301509's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 808 | Fumin Wang | www.kingchemchina.com |
Kingchem (Liaoning) Life Science Co., Ltd. operates as a CDMO company for pharmaceutical, electronic chemicals, and fine and specialty chemicals sectors worldwide. It offers alkanes, aromatic, compounds, trifluoromethoxybenzenes, fluorobenzenes, pyrrolidines, trifluorotoluenes, indenes, isoquinolines, piperidines, naphthalenes, piperazines, pyranes, isocyanates, pyrazines, pyridines, quinoxalines, pyrimidines, indanones, purines, thiophenes, phenanthrolines, carbazoles, thiomorpholines, morpholines, triazoles, imidazoles, pyrazoles, quinolines, benzofurans, indoles, tetralones, fluorinated reagents, and other fluorinated compounds.
Kingchem (Liaoning) Life Science Co., Ltd. Fundamentals Summary
| 301509 fundamental statistics | |
|---|---|
| Market cap | CN¥3.36b |
| Earnings (TTM) | CN¥93.77m |
| Revenue (TTM) | CN¥596.78m |
37.9x
P/E Ratio5.9x
P/S RatioIs 301509 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301509 income statement (TTM) | |
|---|---|
| Revenue | CN¥596.78m |
| Cost of Revenue | CN¥349.40m |
| Gross Profit | CN¥247.39m |
| Other Expenses | CN¥153.62m |
| Earnings | CN¥93.77m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.78 |
| Gross Margin | 41.45% |
| Net Profit Margin | 15.71% |
| Debt/Equity Ratio | 0% |
How did 301509 perform over the long term?
See historical performance and comparison